Skip to main content
. 2018 Sep 7;9(10):1698–1707. doi: 10.1039/c8md00257f

Table 1. In vitro antibacterial evaluation (MIC) of RDSB analogues 11a–11v against MRSA (JCSC 4788) and standard SA (ATCC 6538).

Comp. R MICMRSA μg mL–1 MICSA μg mL–1 Comp. R MICMRSA μg mL–1 MICSA μg mL–1
11a 256 >256 11l n-C8H17 0.5 0.25
11b H 128 128 11m n-C9H19 0.50 0.50
11c CH3 4.0 4.0 11n n-C10H21 1.0 1.0
11d C2H5 2.0 2.0 11o n-C11H23 8.0 8.0
11e n-C3H7 2.0 2.0 11p n-C13H27 256 128
11f i-C3H7 4.0 4.0 11q n-C15H31 >256 >256
11g n-C4H9 1.0 0.5 11r c-C4H7 8.0 4.0
11h i-C4H9 1.0 0.5 11s c-C5H9 4.0 4.0
11i n-C5H11 0.5 0.5 11t c-C6H11 4.0 2.0
11j n-C6H13 0.5 0.25 11u CH2Ph 4.0 4.0
11k n-C7H15 0.25 0.25 11v C2H4Ph 2.0 2.0
1 1.0 1.0 Van. 1.0 0.5